PASSION POWER TO TO INNOVATE CHANGE
Institute for Pharmaceutical Industry Fellowships
Program History Rutgers Program History Professional Development Series FOSTER Key Program Features Application & Eligibility Requirements
About Bayer Leadership Team Bayer Consumer Health Bayer Pharmaceuticals Fellowship Alumni
In 1984, at Rutgers, The State University of New Jersey, the Ernest Mario School of Pharmacy and two pharmaceutical companies began a collaborative pilot program to evaluate the potential contributions of clinically-trained pharmacists within a pharmaceutical industry practice setting. Following the successful pilot, the Rutgers Pharmaceutical Industry Fellowship (RPIF) Program grew significantly and expanded to include 19 companies within the pharmaceutical and biopharmaceutical industries and over 160 fellows annually. In 2002, Dr. Ernest Mario generously provided an endowment to establish the Institute for Pharmaceutical Industry Fellowships to enhance and promote the role of pharmacists in industry through the RPIF Program. The Institute staff members: •
provide leadership and administrative support;
•
promote quality, communication, and scholarly activity; and
•
arrange specialized fellowship training opportunities within the pharmaceutical and biopharmaceutical industries.
2016 RPIF Program Certificate Dinner
The RPIF Program has thrived under the leadership of the founder, Dr. Joseph A. Barone, Dean and Distinguished Professor II of the Ernest Mario School of Pharmacy and Dr. Michael Toscani, Research Professor and the Fellowship Director for the Institute for Pharmaceutical Industry Fellowships. More than 850 post-doctoral fellows have completed the RPIF Program, most of whom are pursuing influential and rewarding careers in the pharmaceutical and biopharmaceutical industries throughout the U.S. and abroad. The RPIF Program has preceptors/mentors from industry who share their knowledge and experiences with the fellows through an intense but closely-guided training program. Assignments and projects are challenging, meaningful, and designed to enhance understanding of the pharmaceutical and biopharmaceutical industries and the fellow’s functional area.
Joseph A. Barone, PharmD, F.C.C.P. Dean and Professor II Ernest Mario School of Pharmacy
Michael Toscani, PharmD Research Professor, Fellowship Director, Institute for Pharmaceutical Industry Fellowships
2
Institute for Pharmaceutical Industry Fellowships
Professional Development Series Rutgers Program History Professional Development Series FOSTER Key Program Features Application & Eligibility Requirements
About Bayer Leadership Team Bayer Consumer Health Bayer Pharmaceuticals Fellowship Alumni
All fellows gather at Rutgers once or twice monthly as a group to participate in the Professional Development Day (PDD) Series, an important component of their training that complements the handson experience provided at the partner companies. The PDDs are steered by a committee of fellows and are designed to enhance the fellows’ presentation skills, emotional intelligence, promote connectivity and a sense of community among fellows from different companies and disciplines, develop new skill sets under the guidance of external trainers, and provide general knowledge about various aspects of drug development and issues facing the pharmaceutical and biopharmaceutical industries.
The fellows learn from each other through individual and group presentations and debates on topics and issues related to the pharmaceutical and biopharmaceutical industries. This dynamic forum provides an opportunity for open discussion and debate among fellows, Rutgers faculty, and company preceptors. In addition, outside experts provide training and professional development in a variety of areas (e.g., tools for corporate success; professional writing, presentations, meeting facilitation, negotiating, influencing, networking, and conflict resolution skills; giving and receiving feedback; and business and dining etiquette). Other PDD guest speakers include industry executives, patient advocacy groups, and successful RPIF Program alumni who share their insights and experiences. Importantly, PDDs provide an excellent opportunity for fellows to interact with each other and develop lasting personal friendships and a strong professional network of fellows, faculty, alumni, and other industry executives.
3
Institute for Pharmaceutical Industry Fellowships
Key Program Features Rutgers Program History Professional Development Series FOSTER Key Program Features Application & Eligibility Requirements
About Bayer Leadership Team Bayer Consumer Health Bayer Pharmaceuticals Fellowship Alumni
The Rutgers Pharmaceutical Industry Fellowship Program FOSTERs the growth and development of future pharmaceutical and biopharmaceutical industry professionals through the following key program features:
F O S T E R
Family of Leading Companies Outstanding Alumni Track Record
Partners include several of the top 19 global pharmaceutical and biopharmaceutical companies.
Over 850 alumni hold prominent positions at many leading companies.
Strong Network
Over 160 fellows each year develop valuable, lasting connections with each other, alumni, preceptors and faculty.
The Pathway to Industry
Since 1984, the Rutgers program has been nationally recognized, trusted, and proven as the pathway to industry for pharmacists.
Enhanced Career Path
Increasingly challenging assignments build depth of experience and enhance the potential for an accelerated career path.
Rigorous Academic Component
Rutgers affiliation provides academic and professional development opportunities.
4
Institute for Pharmaceutical Industry Fellowships
Key Program Features Rutgers Program History Professional Development Series FOSTER Key Program Features Application & Eligibility Requirements
Rutgers, The State University of New Jersey, with approximately 65,000 students in its three campuses, is one of the major state university systems in the United States. The New Jersey College of Pharmacy was founded in 1892 and was incorporated into the University in 1927. The Ernest Mario School of Pharmacy is the only state school of pharmacy in New Jersey, with approximately 1,400 students in its Doctor of Pharmacy program.
About Bayer Leadership Team Bayer Consumer Health Bayer Pharmaceuticals Fellowship Alumni
Ernest Mario School of Pharmacy Rutgers, The State University of New Jersey
The Rutgers Ernest Mario School of Pharmacy is located on the University’s main science and technology campus in Piscataway, New Jersey. Because of its close proximity to the nation’s leading pharmaceutical and biopharmaceutical companies, the Ernest Mario School of Pharmacy and the RPIF Program are uniquely capable of providing fellows with exposure to the pharmaceutical and biopharmaceutical industries.
5
Institute for Pharmaceutical Industry Fellowships
Application Process and Eligibility Requirements Rutgers Program History Professional Development Series FOSTER Key Program Features Application & Eligibility Requirements
About Bayer Leadership Team Bayer Consumer Health Bayer Pharmaceuticals Fellowship Alumni
Please Address All Correspondence To
Joseph A. Barone, Pharm.D., F.C.C.P. Dean and Professor II Ernest Mario School of Pharmacy Rutgers, The State University of New Jersey 160 Frelinghuysen Road Piscataway, NJ 08854-8020
Fellows for the Rutgers Pharmaceutical Industry Fellowship Program are selected on a nationally-competitive basis. Candidates must have completed a Doctor of Pharmacy degree from an ACPE accredited institution before July 1 of the fellowship term. Participation in the ASHP Midyear Clinical Meeting/ PPS is strongly encouraged. Interested individuals are invited to electronically submit a curriculum vitae, three letters of recommendation and a letter of intent and complete a program interest form online by visiting our website at pharmafellows.rutgers.edu
Application materials may be submitted as early as November 19, and applicants are encouraged to submit as many of the required materials as possible by December 15.
6
About Bayer Rutgers About Bayer About Bayer’s LIFE Values Your Time at Bayer Fellowship Program
Leadership Team Bayer Consumer Health Bayer Pharmaceuticals Fellowship Alumni
Bayer’s mission is to research, develop, manufacture and market innovative products that improve the health of people and animals throughout the world. Throughout its 150-year history, Bayer has -- and continues to -- re-imagine science to transform lives, focusing on inventing new solutions that improve the health of patients, consumers, communities and families. As one of the most recognized brands in the world today, Bayer considers innovation to be part of the company’s DNA. Bayer’s healthcare business has operations in over 100 countries and employs 55,700 people worldwide. As one of the world’s foremost innovators in the field of pharmaceutical and medical products, Bayer provides products that healthcare providers and patients can trust. Its success is based on translating scientific findings into new medications and products that customers and society need. Doing this requires innovative thinking, dedication and a relentless focus on doing the right thing. These core values set Bayer apart with an industry-leading portfolio of products and support that healthcare providers and their patients require. Bayer has four operating divisions: Pharmaceuticals, Consumer Health, Crop Science, and Animal Health.
Bayer US Headquarters
New Headquarters in Whippany In the U.S., Bayer opened its new headquarters in Whippany, NJ in mid-2013, bringing together employees from several sites in the New York/New Jersey area. The 700,000 sq. ft., state of the art facility is situated on 94 acres of property in a thriving suburb, with easy access to several major highways. The secure-access site features desirable amenities, such as a fitness center, large café, outdoor dining area, medical suite, coffee bar, company store and a modern, open office floor plan. The official grand opening of the new Whippany headquarters was on October 16th, 2013.
7
About Bayer Bayer’s LIFE Values
Rutgers
By working sustainably and accepting our role as a socially and ethically responsible corporate citizen – and by committing to our Bayer values – we create benefits for the communities in which we live. Science For A Better Life: this is the promise we all give to our stakeholders.
About Bayer About Bayer’s LIFE Values Your Time at Bayer Fellowship Program
Leadership Team Bayer Consumer Health Bayer Pharmaceuticals Fellowship Alumni
Leadership
Integrity
Flexibility
Efficiency
Leadership means much more than retaining and extending our market positions. It applies to all our employees, not just managers.
Following the rules of law and regulations is a given to Bayer. Our integrity enhances the legitimacy of our operations and strengthens our reputation.
In today’s everchanging business landscape, the ability to adapt to different situations is crucial for future success.
Efficiency implies our overall approach to make the best possible use of our resources, thus improving our overall performance.
8
About Bayer Your Time at Bayer
Rutgers About Bayer About Bayer’s LIFE Values Your Time at Bayer Fellowship Program
Leadership Team
PASSION POWER TO TO INNOVATE CHANGE
Bayer Consumer Health
As a fellow at Bayer, you will be exposed to a variety of exciting opportunities that will enable you to become a leader in the pharmaceutical industry. Bayer’s new employer brand promise describes what we expect from our employees and potential candidates, and explains how each employee can succeed in the company. This employer brand promise, “Passion to Innovate | Power to Change” exemplifies our presence as a global giant and is supported by four underlying key promises that the fellow can expect upon entering the company. These four promises serve as pillars for what makes our working culture so special.
Bayer Pharmaceuticals Fellowship Alumni At Bayer you have the freedom and the license to question the status quo and think ahead.
At Bayer you can engage in open and inspiring work with people who share your passion to turn pioneering ideas into life-changing solutions.
At Bayer our ideas are inspired by society’s most fascinating challenges to enhance the lives of many, and our thinking is driven by our customers’ needs.
At Bayer you are empowered to make an impact by being part of a leading company that has the power and endurance it takes to improve life – not only in today’s but in tomorrow’s world.
9
About Bayer Rutgers About Bayer About Bayer’s LIFE Values Your Time at Bayer Fellowship Program
Leadership Team
PHARMACEUTICALS The U.S. Bayer Pharmaceuticals business, headquartered in Whippany, New Jersey, provides specialty pharmaceutical products in the areas of Hematology, Neurology, Oncology, Cardiopulmonary, and Women’s Healthcare. Multiple products have been approved recently in the U.S. across all of Bayer's therapeutic areas. The company also recently expanded its Women’s Healthcare portfolio, making Bayer the only company to offer a full range of contraception options to women- short-acting, long-acting and permanent.
Bayer Consumer Health Bayer Pharmaceuticals Fellowship Alumni
Bayer Pharmaceuticals Fellows
CONSUMER HEALTH Bayer Consumer Health, with its U.S. headquarters in Whippany, New Jersey, is among the top consumer healthcare companies in the world, with products in the categories of Analgesics; Cold, Allergy, Sinus, & Flu; OTC and Rx Dermatology including Sun Care; Foot Health; Gastrointestinals and Nutritionals. Some of the most trusted and recognizable brands in the world today come from the Bayer portfolio of products. These include Afrin®, Aleve®, Alka-Seltzer®, Alka-Seltzer Plus®, Apronax®, Aspirin™, Bayer® Aspirin, Bepanthen™, Bepanthol™, Berocca®, Cal-D-Vita/Elevit™, Canesten™, Claritin®, Coppertone®, Dr. Scholl’s®, Flanax™, Flintstones™ Vitamins, Midol®, MiraLAX®, One A Day® Vitamins, Oxytrol® for Women, Phillips’® Milk of Magnesia, Redoxon™, Rennie™. Bayer Consumer Health Fellows
10
Leadership Team Executive Sponsors
Rutgers About Bayer Leadership Team Executive Sponsors Program Directors
“The Fellowship Program provides graduates with a well-rounded and robust exposure to the pharmaceutical industry. Our preceptors are dedicated and committed healthcare professionals with extensive academic and pharmaceutical expertise. Our fellows graduate with an unforgettable experience that can ultimately lead to a gratifying career in the pharmaceutical industry.” Juan C. Nadal, M.D.
VP, Medical Communications (Pharmaceuticals)
Bayer Consumer Health Bayer Pharmaceuticals Fellowship Alumni
“PharmDs are customer focused and bring the science and medicine to our commercial evaluations. We cannot have one without the other; the expertise PharmDs can bring is invaluable to the work we do here at Bayer.” Yasmin Islami, MBA
Senior Director and Head, Early Product Commercialization, Region U.S. (Pharmaceuticals)
“As an alumnus of the Rutgers Fellowship, I am proud to be a part of the Bayer Fellowship Program which, as one of the most diverse programs available, will provide you with a strong foundation necessary for a successful career in the pharmaceutical industry.”
Todd Paporello, PharmD, MBA
VP, Head of North American Regulatory Affairs. Pharmaceuticals and Consumer Health
11
Leadership Team Program Directors
Rutgers About Bayer Leadership Team Executive Sponsors Program Directors
Bayer Consumer Health Bayer Pharmaceuticals Fellowship Alumni
“The Bayer/Rutgers Fellowship Program provides the new graduate with a diversified educational and practical exposure to the pharmaceutical industry. Fellows who complete this program and then enter the pharmaceutical industry will bring with them crossfunctional team experiences that will smooth their transition as new hires in the industry.” Mark Rametta, DO, FACOI, FACP
Medical Director in U.S. Medical Affairs-Neurology
“Bayer is a great company for pharmacists entering the pharmaceutical industry, and those involved in the PharmD fellowship program are committed to providing pharmacists with the guidance and training necessary to become successful within the organization.” Anthony Genovese, PharmD
Deputy Director, Advertising & Promotion, Global Regulatory Affairs
“The fellowship program in Global Clinical Sciences Operations provides longitudinal exposure within early clinical development (PhI & II). Providing “hands on” valuable clinical trial management experience while building on science & leadership to prepare for strong career in the pharmaceutical industry.” Stephen Kaesshaefer, MS, MBA, PMP
Head of Clinical Operations Project Leaders, Early Development Oncology
"The Bayer/Rutgers fellowship program offers a distinctive path to gaining practical experiences and leadership opportunities that build a strong foundation for a successful career within the pharmaceutical industry. The mentors are dedicated to creating opportunities for the fellows to work on challenging and highly visible projects that facilitate advancement of their technical and professional proficiencies while making valuable contributions within the organization." Palak Venkataraman PharmD, RPh.
Senior Associate Director in Medical Affairs, Bayer Consumer Health
"The Bayer/Rutgers Fellowship track focusing on Commercial Pharmaceutical Business is a unique opportunity for our advanced PharmD graduates to gain valuable real-world experience participating & leading in meaningful commercial assignments and opportunities at a global leading biopharmaceutical company. Fellows that complete the two-year program will acquire relevant commercial pharmaceutical learnings, perspectives and accomplishments that will serve them as they build their own professional career path in this patient-centric Industry." James Serpico RPh, MBA
Deputy Director, New Product Commercialization U.S. Rare Diseases & Cardio
12
Bayer Consumer Health Division Rutgers About Bayer
PROGRAM DIRECTOR
Leadership Team Bayer Consumer Health About Global Medical Affairs & Clinical Development U.S. Regulatory Affairs Global Product Development & Innovation Global Pharmacovigilance & Product Quality/Safety I&D Category Leadership Rx-to-OTC Switch
Palak Venkataraman PharmD, RPh.
Senior Associate Director in Medical Affairs, Bayer Consumer Health
Bayer Pharmaceuticals Fellowship Alumni
Fellowship Departments: Global Medical Affairs & Clinical Development U.S. Regulatory Affairs Global Product Development & Innovation Global Pharmacovigilance and Product and Quality Safety Innovation, Research & Development Category Leadership Rx-to-OTC Switch
Bayer Consumer Health Leadership Team
13
Bayer Consumer Health Division Consumer Health | Global Medical Affairs & Clinical Development
Rutgers About Bayer
2 YEAR FELLOWSHIP
Leadership Team Bayer Consumer Health About Global Medical Affairs & Clinical Development U.S. Regulatory Affairs Global Product Development & Innovation Global Pharmacovigilance & Product Quality/Safety I&D Category Leadership Rx-to-OTC Switch
Bayer Pharmaceuticals Fellowship Alumni
Current Bayer Consumer Health Fellows
• Propel the Consumer Health business through medical and product insights and innovations in clinical research • Develop new claims, indications, and dosage forms for OTC products • Design, conduct, and support clinical research activities using vigorous scientific methodologies and Good Clinical Practice (GCP) • Maintain scientific and clinical expertise to support currently marketed products, participate in the review of advertising and promotional material, and provide medical support to marketing initiatives • Collect, review, assess, and disseminate scientific and clinical information as it relates to the company products or competitive products
Alisha Couto, PharmD MCPHS University, 2nd Year Fellow
Jennifer Moon, PharmD
Philadelphia College of Pharmacy, 1st Year Fellow
Current Bayer Consumer Health Preceptors
• Interact regularly with all members of the global and/or U.S. clinical development teams, as well as other functions, particularly Regulatory Affairs and Project Management • Provide support for the strategy, coordination, and implementation of advisory board meetings and FDA advisory committee meetings • Collaborate with key opinion leaders
Palak Venkataraman, PharmD, RPh
Senior Associate Director in Medical Affairs, Bayer Consumer Health
14
About Bayer
RE C NO RU T IT IN G
Rutgers
Bayer Consumer Health Division Consumer Health | U.S. Regulatory Affairs
2 YEAR FELLOWSHIP
Leadership Team Bayer Consumer Health About Global Medical Affairs & Clinical Development U.S. Regulatory Affairs Global Product Development & Innovation Global Pharmacovigilance & Product Quality/Safety I&D Category Leadership Rx-to-OTC Switch
Bayer Pharmaceuticals Fellowship Alumni
Current Bayer Consumer Health Fellows
• Assist in the development, review and approval of labeling and promotional activities • Participate in the preparation of regulatory strategies to support the development of innovative new products • Work with various departments within the organization to ensure compliance with existing and proposed regulations • Interface with regulatory colleagues who support our products on a local level • Contribute to the authoring of submissions to various regulatory agencies
Fenan Solomon, PharmD University of Maryland, 2nd Year Fellow
Current Bayer Consumer Health Preceptors
• Cultivate internal and external professional relationships to help further Bayer sponsored initiatives • Assist in the management of regulatory issues which have the potential to impact our products in the global market
Dawn Jackman
Senior Associate Director, U.S. Regulatory Affairs
15
Bayer Consumer Health Division Consumer Health | Global Product Development & Innovation
Rutgers About Bayer Leadership Team Bayer Consumer Health About Global Medical Affairs & Clinical Development U.S. Regulatory Affairs Global Product Development & Innovation Global Pharmacovigilance & Product Quality/Safety I&D Category Leadership Rx-to-OTC Switch
Bayer Pharmaceuticals Fellowship Alumni
2 YEAR FELLOWSHIP
Current Bayer Consumer Health Fellows
• Develop innovative OTC/nutritional supplement products for Bayer Consumer Health
• Design and implement pre-formulation, formulation, process, project timelines and basic analytical activities for new products using Quality by Design principles
• Perform experiments in the laboratory to formulate and test prototypes, develop a manufacturing process, and scale-up the product
• Actively engage in literature and patent searches related to products • Participate in consumer insights based new product ideation and product design sessions
• Help design and refine prototypes with the consideration of product stability, regulatory and medical acceptability
Khyati Desai, PharmD, MS Nova Southeastern University, 2nd Year Fellow
Jessica Giaquinto, PharmD Butler University, 1st Year Fellow
Current Bayer Consumer Health Preceptors
• Interact regularly with all members of the Global Innovation and Development Teams and cross-functional members of the Core Team
• Assist with managing the product development process from concept phase to the post-launch analysis phase
• Write development plans, reports, and CMC technical regulatory documents for projects and share scientific work with other functions
• Author and review chemistry, manufacturing, and controls (CMC) sections
(Module 3) of Global Dossiers, variations of currently registered products, and quality overall summaries of dossiers
• Interact with manufacturing sites, Global and Local Regulatory colleagues to gain alignment on CMC documentation
Henri Marion
Senior Associate Director, Technical Lead
Yu Shao, PhD
Senior Associate Director Formulation Development
Jerry Meisel
Vice President, Global Innovation & Development Center - Morristown
16
About Bayer
RE C NO RU T IT IN G
Rutgers
Bayer Consumer Health Division
Consumer Health | Global Pharmacovigilance and Product and Quality Safety
2 YEAR FELLOWSHIP
Leadership Team Bayer Consumer Health About Global Medical Affairs & Clinical Development U.S. Regulatory Affairs Global Product Development & Innovation Global Pharmacovigilance & Product Quality/Safety I&D Category Leadership Rx-to-OTC Switch
Bayer Pharmaceuticals Fellowship Alumni
Current Bayer Consumer Health Fellows
• Prepare safety assessments for new and existing products including medical products, and medical devices • Work in a global safety environment applying skills and knowledge in a multi-national regulatory environment • Collaborate with colleagues in medical affairs, clinical development and regulatory affairs to conduct benefit risk assessments • Develop risk mitigation strategies in support of bringing new products to market • Contribute to the preparation of a variety of scientific and regulatory documents including Common Technical Documents, Periodic Benefit-Risk Evaluation Reports, and labeling justification documents
Justin Mathew, PharmD
Philadelphia College of Pharmacy, 1st Year Fellow
Current Bayer Consumer Health Preceptors
Jadine Stephan, RPh
Global Safety Leader, Global Drug Safety
17
About Bayer Leadership Team Bayer Consumer Health About Global Medical Affairs & Clinical Development U.S. Regulatory Affairs Global Product Development & Innovation Global Pharmacovigilance & Product Quality/Safety I&D Category Leadership Rx-to-OTC Switch
Bayer Pharmaceuticals Fellowship Alumni
RE C NO RU T IT IN G
Rutgers
Bayer Consumer Health Division Consumer Health | Innovation & Development Category Leadership
2 YEAR FELLOWSHIP Current Bayer Consumer Health Fellows
• Investigate scientific leads into new / emerging technology that may deliver meaningful benefit to our consumers, and translates it into highly relevant consumer experiences and high value new products • Support the identification of consumer-compelling innovative products and claims that form the basis of a differentiated, sustainable pipeline • Participate on the I* R&D Category Leadership Team, which is a cross functional team responsible to drive innovation in I*R&D that is consistent with our business strategies • Gain cross-functional knowledge of drug development
Daina Nanchanatt, PharmD Temple University, 1st Year Fellow
Current Bayer Consumer Health Preceptors
• Leverage the science of the therapeutic category and insights into consumer needs to support a scientifically robust pipeline of highly-valued consumer products/claims • Support a stronger link between the commercial organization and R&D organization
Margaret Gryszkiewicz, PharmD
Director, R&D Category Technical Lead
18
About Bayer
RE C NO RU T IT IN G
Rutgers
Bayer Consumer Health Division Consumer Health | Rx-to-OTC Switch
2 YEAR FELLOWSHIP
Leadership Team Bayer Consumer Health About Global Medical Affairs & Clinical Development U.S. Regulatory Affairs Global Product Development & Innovation Global Pharmacovigilance & Product Quality/Safety I&D Category Leadership Rx-to-OTC Switch
Bayer Pharmaceuticals Fellowship Alumni
Current Bayer Consumer Health Fellows
• Support all phases of a Switch project in the role of a Switch Team member through assisting with: • Assessment of new prescription molecules for Switch potential • Scientific/medical support for preliminary commercial assessments • Creation of development plans • Drafting regulatory dossiers • Scientific/medical support for development of commercialization strategy, plans, execution and launch
Maggie Gandhi, PharmD
Philadelphia College of Pharmacy, 1st Year Fellow Current Bayer Consumer Health Preceptors
• Technology-enablement and innovation applied to switch of molecules in need of special requirements beyond the traditional path to market, i.e. Drug Facts Labeling • Key interfaces: • Bayer Pharmaceutical functions • Licensing partners • Global Functions and Resources Supporting Pharmaceutical and Consumer Health, e.g. Medical Affairs, Safety/Toxicology, Pharmacovigilance, Pharmacoepidemiology, Clinical Operations, R&D Information Center, Consumer Science, Development Centers of Excellence, Regulatory Affairs
Amy Replogle, M.S.
Director, Rx to OTC Switch Science
19
Bayer Pharmaceuticals Division Rutgers
PROGRAM DIRECTOR
About Bayer
Fellowship Departments:
PROGRAM DIRECTOR
Medical Communications Medical Science Liaison (Oncology)
Leadership Team
Business Development & Licensing Early Pipeline Strategic Marketing Corporate & Government Customers/U.S. Managed Markets Business Unit Global Market Access/Health Economics & Outcomes Research Rare Disease Business Unit New Product Commercialization
Bayer Consumer Health Bayer Pharmaceuticals About Medical Communications Medical Science Liaison (Oncology) Medical Affairs (Oncology) Global Pharmacovigilance Business Development & Licensing Early Pipeline Strategic Marketing Brand Marketing, U.S. Managed Markets Marketing, Rare Diseases Business Unit New Product Commercialization Global Market Access Global Regulatory Affairs Clinical Operations
Fellowship Alumni
Mark Rametta, DO, FACOI, FACP
James Serpico, RPh, MBA
Medical Director in US Medical Affairs Neurology
PROGRAM DIRECTOR
Fellowship Departments:
Deputy Director, New Product Commercialization, U.S. Rare Diseases and Cardiology
Fellowship Departments: Global Regulatory Affairs
Anthony Genovese, PharmD
Deputy Director, Advertising & Promotion, Global Regulatory Affairs
PROGRAM DIRECTOR
Fellowship Departments: Clinical Operations
Stephen Kaesshaefer, MBA
Head of Operations Project Support, Oncology
Bayer Pharmaceuticals Leadership Team
20
Bayer Pharmaceuticals Division Medical Affairs | Medical Communications
Rutgers About Bayer Leadership Team Bayer Consumer Health Bayer Pharmaceuticals About Medical Communications Medical Science Liaison (Oncology) Medical Affairs (Oncology) Global Pharmacovigilance Business Development & Licensing Early Pipeline Strategic Marketing Brand Marketing, U.S. Managed Markets Marketing, Rare Diseases Business Unit New Product Commercialization Global Market Access Global Regulatory Affairs Clinical Operations
Fellowship Alumni
2 YEAR FELLOWSHIP
Current Bayer Pharmaceuticals Fellows
• Provide balanced, written, and verbal
scientific responses to inquiries from health care professionals in a compliant manner
• Identify, document, and process adverse events and product complaints
• Research medical literature and evaluate scientific data to develop evidencebased medical content for responses
Amy Zhou, PharmD
• Review advertising and promotional
Rutgers University, 1st Year Fellow
materials to ensure medical accuracy
Valentina Pampulevski, PharmD Philadelphia College of Pharmacy, 1st Year Fellow
• Collaborate with cross-functional
team members to ensure advertising and promotional materials meet legal, medical, regulatory and commercial objectives
Current Bayer Pharmaceuticals Preceptors
• Provide medical information booth support at medical conferences
• Develop medical educational materials
and present lectures to sales training groups and other company employees Frank Pignataro, PharmD
Director, Medical Information Services
Solveig Halldorsdottir, PhD Director, Medical Information Services
Saleem Noormohamed, PharmD, MBA
Deputy Director, Medical Information Services- Oncology
Tara Pummer, PharmD Deputy Director, Medical Information ServicesWomen's Healthcare
21
About Bayer
RE N C EW RU L IT Y IN G
Rutgers
Bayer Pharmaceuticals Division Medical Affairs | Medical Science Liaison (Oncology)
2 YEAR FELLOWSHIP
Current Bayer Pharmaceuticals Fellows
Leadership Team Bayer Consumer Health Bayer Pharmaceuticals About Medical Communications Medical Science Liaison (Oncology) Medical Affairs (Oncology) Global Pharmacovigilance Business Development & Licensing Early Pipeline Strategic Marketing Brand Marketing, U.S. Managed Markets Marketing, Rare Diseases Business Unit New Product Commercialization Global Market Access Global Regulatory Affairs Clinical Operations
Fellowship Alumni
• The Fellow will work with the U.S. Medical Affairs Oncology Department during their tenure in the Fellowship Program • Engage in the exchange of data and knowledge in a scientific and balanced manner as they relate to clinical research, disease state awareness, pipeline assets, and therapeutic trends • Gain an understanding of thought leader (TL) engagement, mapping, and territory management by developing and fostering relationships with critical stakeholders, TLs, Health Care Professionals (HCPs) and institutions • Attend and actively participate in relevant scientific and professional meetings, including major medical meetings and Bayer Advisory Boards
Tony Luu, PharmD
University of Southern California, 2nd Year Fellow
Current Bayer Pharmaceuticals Preceptors
• Participate in the review process and discussion strategy for Investigator Initiated Research (IIR) as well as Company Sponsored Studies (CSS) • Evaluate funding requests for Continuing Medical Education and Grants (as needed) Cynthia Quince, PharmD
National Director Oncology MSLs
Matt Fisher, PharmD
Deputy Director, Medical Science Liason-Oncology
22
About Bayer Leadership Team Bayer Consumer Health Bayer Pharmaceuticals About Medical Communications Medical Science Liaison (Oncology) Medical Affairs (Oncology) Global Pharmacovigilance Business Development & Licensing Early Pipeline Strategic Marketing Brand Marketing, U.S. Managed Markets Marketing, Rare Diseases Business Unit New Product Commercialization Global Market Access Global Regulatory Affairs Clinical Operations
Fellowship Alumni
RE C NO RU T IT IN G
Rutgers
Bayer Pharmaceuticals Division Medical Affairs | Oncology
2 YEAR FELLOWSHIP
Current Bayer Pharmaceuticals Fellows
• Gain hands-on experience within the global team of Medical Affairs Oncology over the course of the fellowship program
• Rotate through various Medical Affairs Functional groups including, publications, scientific communications, operations and pipeline:
• Assist in the development of a life-cycle management strategy that
improves the clinical care of patients by addressing unmet medical needs through various channels (ex. phase IV trials, investigator-initiated research (IIRs), real world data, etc.)
• Draft and provide input in the design, conduct and support of clinical research studies
• Review investigator-initiated research proposals , participate in review
Sarah Ullman, PharmD
Long Island University College of Pharmacy, 1st year Fellow
committee and process
• Participate in publication subcommittee meetings to plan and implement appropriate publication strategies and tactics for Bayer oncology drugs
Current Bayer Pharmaceuticals Preceptors
• Develop content and ensure the accuracy and scientific quality of
manuscripts as well as abstracts, posters, and oral presentations of the latest clinical data at Bayer symposia, international congresses, and other educational programs
• Develop internal global communications and education for Bayer oncology products
• Develop high-quality (relevant, rigorous, balanced) global medical information documents for healthcare customers in response to unsolicited inquiries about Bayer oncology products
• Provide medical review of Bayer product materials in collaboration with
a cross-functional team and communicate product information to health care professionals and customers
Teresa Rafferty, RN, MBA
Head of Operational Excellence and Project Management
• Assist in coordination and planning of advisory board meetings 23
About Bayer
RE N C EW RU L IT Y IN G
Rutgers
Bayer Pharmaceuticals Division
Pharmacovigilance | Global Pharmacovigilance and Product and Quality Safety
2 YEAR FELLOWSHIP
Current Bayer Pharmaceuticals Preceptors
Leadership Team Bayer Consumer Health Bayer Pharmaceuticals About Medical Communications Medical Science Liaison (Oncology) Medical Affairs (Oncology) Global Pharmacovigilance Business Development & Licensing Early Pipeline Strategic Marketing Brand Marketing, U.S. Managed Markets Marketing, Rare Diseases Business Unit New Product Commercialization Global Market Access Global Regulatory Affairs Clinical Operations
• Critically evaluate and communicate scientific information regarding Bayer and competitor products • Prepare safety assessments for new and existing products including pharmaceuticals, medical devices and combination products • Work in a global safety environment applying skills and knowledge across different geographies and cultures • Collaborate with colleagues in a multi-disciplinary setting to conduct benefit:risk assessments and risk minimization plans for existing and new products. These disciplines include medical affairs, clinical development, regulatory affairs and etc. Rotations in other functional areas can be arranged
Joel Krasnow, M.D.
Global Safety Leader, Global Drug Safety
• Draft scientific and regulatory documents including Common Technical Documents, Periodic Benefit-Risk Evaluation Reports, and labeling justification documents
Fellowship Alumni
24
About Bayer Leadership Team Bayer Consumer Health Bayer Pharmaceuticals About Medical Communications Medical Science Liaison (Oncology) Medical Affairs (Oncology) Global Pharmacovigilance Business Development & Licensing Early Pipeline Strategic Marketing Brand Marketing, U.S. Managed Markets Marketing, Rare Diseases Business Unit New Product Commercialization Global Market Access Global Regulatory Affairs Clinical Operations
RE C NO RU T IT IN G
Rutgers
Bayer Pharmaceuticals Division Commercial | Business Development & Licensing
2 YEAR FELLOWSHIP
Current Bayer Pharmaceuticals Fellows
• Pro-actively identify BD&L opportunities to complement the U.S. portfolio and implement the U.S. BD strategy • Interpret scientific and medical information to assess attractiveness of targets for in-licensing, acquisitions, and partnering deals • Integrate market and commercial data to support evaluation of portfolio development opportunities • Actively collaborate with cross-functional teams from Medical Affairs, Regulatory Affairs, Intellectual Property, and Marketing in due diligence assessments • Work with senior members of the BD&L team to provide recommendations and U.S. perspectives to global projects and strategy
Mark Youssef, PharmD Rutgers University, 1st Year Fellow
Ikechukwu Oji, PharmD
Howard University College of Pharmacy, 1st Year Fellow
Current Bayer Pharmaceuticals Preceptors
• Fellows in this position will have primary responsibilities supporting the RX/Pharmaceuticals business
Fellowship Alumni Frederick Nelson, MBA
Deputy Director, Business Development & Licensing – U.S. Region
Bayer Headquarters - Leverkusen, Germany
25
About Bayer
RE C NO RU T IT IN G
Rutgers
Bayer Pharmaceuticals Division Commercial | Early Pipeline Strategic Marketing
2 YEAR FELLOWSHIP
Leadership Team Bayer Consumer Health Bayer Pharmaceuticals About Medical Communications Medical Science Liaison (Oncology) Medical Affairs (Oncology) Global Pharmacovigilance Business Development & Licensing Early Pipeline Strategic Marketing Brand Marketing, U.S. Managed Markets Marketing, Rare Diseases Business Unit New Product Commercialization Global Market Access Global Regulatory Affairs Clinical Operations
Fellowship Alumni
Current Bayer Pharmaceuticals Fellows
• Assist the U.S. Pharma business in ensuring optimal commercial and marketing input is provided and incorporated into pre-Phase 3 global development programs, across all therapeutic areas • Prepare “indication backgrounders”, which integrate scientific, medical, marketing, and business aspects for therapeutic areas being pursued by pipeline compounds • Support preparation of materials for, and actively participate on, cross functional Commercial Development Teams, which are responsible for developing the U.S. input and position for pipeline projects • Coordinate internal process and support preparation for market research studies and competitive intelligence to assess projects with respect to target product profiles, differentiation, opportunities, challenges, and revenue forecasts for pipeline compounds
Peter Chan, PharmD
Bouve School of Pharmacy, 1st year Fellow
Current Bayer Pharmaceuticals Preceptors
• Collaborate with senior members of the U.S. Business Units, Market Access, and Medical Affairs functions to provide U.S. perspectives to Global Project Teams Yasmin Islami, BS, MBA
Senior Director and Head, Early Product Commercialization - Region U.S.
26
Bayer Pharmaceuticals Division Commercial | Brand Marketing, U.S. Managed Markets
Rutgers About Bayer Leadership Team Bayer Consumer Health Bayer Pharmaceuticals About Medical Communications Medical Science Liaison (Oncology) Medical Affairs (Oncology) Global Pharmacovigilance Business Development & Licensing Early Pipeline Strategic Marketing Brand Marketing, U.S. Managed Markets Marketing, Rare Diseases Business Unit New Product Commercialization Global Market Access Global Regulatory Affairs Clinical Operations
Fellowship Alumni
2 YEAR FELLOWSHIP
Current Bayer Pharmaceuticals Fellows
• Gain hands-on experience within Corporate & Government Customers (CGC), Bayer’s U.S. Managed Markets Department
• Serve as U.S. Managed Markets Brand Managers, rotating through Bayer’s therapeutic areas (i.e. Women’s Healthcare, Oncology, Neurology, and Rare Diseases) directly supporting Managed Markets Brand Directors
• Gain a deeper understanding of all managed markets segments and customers (i.e. health plans/PBMs, specialty pharmacy, trade, integrated delivery networks, group purchasing organization, and government)
• Facilitate patient access to Bayer’s product portfolio by collaborating with in-house and field-based managed markets colleagues, crossfunctional teams, key customers, and market access agencies to drive forward business and serve customers by:
Malay Naik, PharmD Rutgers University, 2nd Year Fellow
Pranvi Parekh, PharmD, MBA University of Tennessee, 2nd Year Fellow
Samuel Jensen, PharmD Rutgers University, 1st Year Fellow
Current Bayer Pharmaceuticals Preceptors
• Supporting creation of product value propositions to managed markets customers by working with market research, health economics and outcomes research, medical affairs, and the business unit
• Developing promotional materials for our products and training field-based account executives on appropriate use of pieces
• Managing strategic relationships and projects with agency partners
John Berrios, MBA
Director, Channel Strategy
• Supporting review of marketing materials through the promotional review process with legal, medical, and regulatory colleagues
27
About Bayer Leadership Team Bayer Consumer Health Bayer Pharmaceuticals About Medical Communications Medical Science Liaison (Oncology) Medical Affairs (Oncology) Global Pharmacovigilance Business Development & Licensing Early Pipeline Strategic Marketing Brand Marketing, U.S. Managed Markets Marketing, Rare Diseases Business Unit New Product Commercialization Global Market Access Global Regulatory Affairs Clinical Operations
RE C NO RU T IT IN G
Rutgers
Bayer Pharmaceuticals Division Commercial | Marketing, Rare Diseases Business Unit
2 YEAR FELLOWSHIP
Current Bayer Pharmaceuticals Fellows
Therapeutic Area - Hematology • Develop and roll out patient and healthcare provider focused marketing material, involving management of agency partners in order to meet strategic mandates, budget, and timelines • Manage overall marketing budget and other critical portfolio operations tactics • Lead in product launch project management • Engage in market research, competitive intelligence, and advisory boards • Collaborate with cross-functional partners to ensure proper planning and execution of strategic objectives
Bradley Browning, PharmD, MBA University of Kentucky, 2nd Year Fellow
Current Bayer Pharmaceuticals Preceptors
Fellowship Alumni Sarit Rotman, PharmD, MBA Jennifer Restivo, MBA Director, New Product Commercialization, US Rare Diseases & Cardio
VP, Marketing Hematology
James Serpico, RPh, MBA Deputy Director, New Product Commercialization, U.S. Rare Diseases and Cardiology
28
About Bayer Leadership Team Bayer Consumer Health Bayer Pharmaceuticals About Medical Communications Medical Science Liaison (Oncology) Medical Affairs (Oncology) Global Pharmacovigilance Business Development & Licensing Early Pipeline Strategic Marketing Brand Marketing, U.S. Managed Markets Marketing, Rare Diseases Business Unit New Product Commercialization Global Market Access Global Regulatory Affairs Clinical Operations
RE N C EW RU L IT Y IN G
Rutgers
Bayer Pharmaceuticals Division Commercial | New Product Commercialization
2 YEAR FELLOWSHIP
Current Bayer Pharmaceuticals Preceptors
• Contribute to the execution of commercial activities in the US commercialization/launch readiness plans to ensure crossfunctional alignment and achieve launch preparedness and excellence • Participate in new product teams to help establish commercialization plans for later stage assets • Support brand planning/launch planning process and collaborate with cross-functional teams (including Medical Affairs, Regulatory, Corporate & Government Customers, Global)
Sarit Rotman, PharmD, MBA Director, New Product Commercialization, US Rare Diseases & Cardio
• Compile competitive intelligence and provide data analyses/ reports • Engage in market research activities • Assist in preparing US commercial assumptions and recommendations into US business cases
Fellowship Alumni
29
About Bayer Leadership Team Bayer Consumer Health Bayer Pharmaceuticals About
RE C NO RU T IT IN G
Rutgers
Bayer Pharmaceuticals Division
2 YEAR FELLOWSHIP
Commercial | Global Market Access Current Bayer Pharmaceuticals Fellows
• Drive the pharmaceutical business through market access and payer insights across the development lifecycle • Deliver value optimizing market access strategies and tactics to achieve and maintain access/reimbursement for key brands
Medical Communications Medical Science Liaison (Oncology) Medical Affairs (Oncology) Global Pharmacovigilance Business Development & Licensing Early Pipeline Strategic Marketing Brand Marketing, U.S. Managed Markets Marketing, Rare Diseases Business Unit New Product Commercialization Global Market Access Global Regulatory Affairs Clinical Operations
• Contribute to target product value profiles, market assessments, and clinical trial program design discussions
Fellowship Alumni
• Prepare Global Value Dossiers and related communication tools for use by regional and country colleagues
• Achieve a diverse experience with the methods and practices of health economics and outcomes research • Design, conduct, and support outcomes research studies such as patient preference, and burden of illness evaluations to better characterize patient and population unmet needs through database analysis and literature review
Parth Vashi, PharmD
Howard University College of Pharmacy, 1st Year Fellow Current Bayer Pharmaceuticals Preceptors
• Conduct economic analyses (i.e. budget impact and cost effectiveness) • Develop patient report outcomes (PROs) strategies
Jennifer Pocoski, PharmD, MPH
Global Market Access Strategy, Hematology Deputy Director, GHEOR Specialty Medicine, Bayer Alum, 2007-2009
Brian Cuffel, PhD
VP and Head Market Access, Oncology
30
Bayer Pharmaceuticals Division Regulatory Affairs | Global Regulatory Affairs
Rutgers About Bayer
2 YEAR FELLOWSHIP
Leadership Team Bayer Consumer Health Bayer Pharmaceuticals About Medical Communications Medical Science Liaison (Oncology) Medical Affairs (Oncology) Global Pharmacovigilance Business Development & Licensing Early Pipeline Strategic Marketing Brand Marketing, U.S. Managed Markets Marketing, Rare Diseases Business Unit New Product Commercialization Global Market Access Global Regulatory Affairs Clinical Operations
Fellowship Alumni
Current Bayer Pharmaceuticals Fellows
• Provide regulatory expertise and guidance in all aspects of the drug development process to ensure the production of quality submissions during pre and post-marketing phases • Ensure compliance with Corporate and Regulatory standards allowing for expeditious review and approvals • Maintain marketed products including all promotional activities in compliance with regulatory requirements
Irene Darras, PharmD MCPHS University, 2nd Year Fellow
• Understand and apply the principles of regulatory affairs
Lee Severson, PharmD
Wisconsin-Madison School of Pharmacy, 1st Year Fellow
Current Bayer Pharmaceuticals Preceptors
• Gain working knowledge of regulations, guidelines and standard practices • Develop the operational proficiency of effective regulatory professional • Areas of Opportunity: Global Regulatory Strategy (U.S. & International), U.S. Advertising and Promotion, Global Labeling, Regulatory Intelligence & Analytics, Global CMC management (drugs & biologics), Submission Planning and Management, Consumer Health Regulatory Affairs
Anthony Genovese, PharmD Deputy Director, Advertising & Promotion, Global Regulatory Affairs
Deepika Jalota, PharmD Senior Director, Global Regulatory Affairs Specialty Medicine, Oncology
Jana Bodorova, MSc
Senior Director and Head Regulatory Affairs, Therapeutic Area General Medicine II
31
Bayer Pharmaceuticals Division Global Clinical Sciences | Clinical Operations
Rutgers About Bayer Leadership Team Bayer Consumer Health Bayer Pharmaceuticals About Medical Communications Medical Science Liaison (Oncology) Medical Affairs (Oncology) Global Pharmacovigilance Business Development & Licensing Early Pipeline Strategic Marketing Brand Marketing, U.S. Managed Markets Marketing, Rare Diseases Business Unit New Product Commercialization Global Market Access Global Regulatory Affairs Clinical Operations
2 YEAR FELLOWSHIP
Current Bayer Pharmaceuticals Fellows
• Understand the management of phase I clinical trials from study concept to clinical study report. • Support and lead the study team by managing all activities as defined per SOPs/OI and ensure regular study team meetings • Understand budgeting, payments, accruals, and forecasting • Ensure all relevant IT-systems are updated with current and accurate information • Train and oversee CROs/vendors: kickoff meetings, study start-up, conduct, and closeout • Interact with all members of the clinical development team (regulatory affairs, statistics, data management, medical writing, drug supply, etc)
Jian P. Mei, PharmD University of Michigan, 2nd Year Fellow
Corinne Iacobucci, PharmD Rutgers University, 1st Year Fellow
Current Bayer Pharmaceuticals Preceptors
• Develop protocol/amendment in collaboration with other study team members • Gather and assess patient data review and safety reports
Fellowship Alumni
Andy Hwang, PharmD Senior Study Manager
32
Bayer Fellowship Alumni Employed at Bayer
Rutgers About Bayer Leadership Team Bayer Consumer Health Bayer Pharmaceuticals Fellowship Alumni Employed at Bayer Employed Elsewhere Employed Elsewhere (cont'd)
Alyson Sous Andrikanich, PharmD
Arthur Graber, PharmD
Greg Balani, PharmD
Andrianna Guo, PharmD
Sabrina Meyers, PharmD
Bayer Fellow, 2012-2014 Global Franchise Manager, Women's HealthCare
Dana Huang, PharmD
Chinelo Okany, PharmD
Ashley Doyle, PharmD
Alice Kim, PharmD
Bayer Fellow, 2013-2015 Medical Science Liaison, Oncology
Bayer Fellow, 2014-2016 Associate Manager, Oncology Sales Strategy and Operations
Paulina Estrada, PharmD
Dan Kim, PharmD
Bayer Fellow, 2009-2011 Associate Director, Advertising & Promotion, Global Regulatory Affairs
Bayer Fellow, 2014-2016 Manager, Global Business Development & Licensing - Consumer Health
Scott Beeman, PharmD, MBA
Bayer Fellow, 2007-2009 Regulatory Strategist, Women's HealthCare
Bayer Fellow, 2014-2015 Medical Science Liaison, Oncology
Bayer Fellow, 2014-2016 Associate Manager, Channel Marketing - Health Plans & PBMs
Bayer Fellow, 2010-2012 Medical Science Liaison, Oncology
Bayer Fellow, 2014-2016 Manager, Regulatory Affairs - Established Products
Omar McMillan, PharmD
Bayer Fellow, 2012-2014 Medical Science Liaison, Hematology
Bayer Fellow, 2008-2010 Medical Science Liaison, Oncology
Bayer Fellow, 2014-2016 Senior Manager, Global CMC Documentation
Jennifer Pocoski, PharmD, M.P.H. Bayer Fellow, 2007-2009 Global Market Access Strategy, Hematology Deputy Director, GHEOR Specialty Medicine
Brittny Rule, PharmD, MBA
Bayer Fellow, 2014-2016 Associate Director of Marketing, Rare Diseases - Cardiology
33
Bayer Fellowship Alumni Employed Elsewhere
Rutgers About Bayer Leadership Team Bayer Consumer Health
Kevin Chan, PharmD
Joosung Kim, PharmD
Theia Monera, PharmD, M.S.
Kim Le, PharmD
Kunal Kunani, PharmD
Mona Patel, PharmD
Meena Ramachandra, PharmD
Rebecca Lalani, PharmD
Bayer Fellow, 2013-2015 Project Manager, US Marketing Insmed, Inc.
Bayer Fellow, 2012-2014 Senior Consultant Navigant Consulting
Bayer Fellow, 2011-2013 Medical Science Liaison CSL Behring
Bayer Pharmaceuticals Fellowship Alumni Employed at Bayer Employed Elsewhere Employed Elsewhere (cont'd)
Bayer Fellow, 2013-2015 Senior Scientific Specialist Merck
Bayer Fellow, 2013-2015 Regulatory Reviewer Food and Drug Administration Office of Prescription Drug Promotion
Kinjal Jariwala, PharmD
Bayer Fellow, 2012-2014 Global Risk Management Plan Associate Manager Novartis
Samantha Forder, PharmD Bayer Fellow, 2014-2016
Bayer Fellow, 2012-2014 Manager, Regulatory Affairs Noven Pharmaceuticals, Inc.
Bayer Fellow, 2011-2013 Therapeutic Manager, Medical Information, Celgene Corporation
Bayer Fellow, 2012-2014 Associate Manager, Regulatory Affairs Advertising and Promotion Gilead
Erica H. Dankiewicz, PharmD
Ruth Kim, M.P.H.
Elbert Chang, PharmD
Bayer Fellow, 2011-2013 Global Oncology Epidemiologist, Forecasting Bristol-Myers Squibb
Bayer Fellow, 2010-2012 Senior Medical Information Specialist Acorda Therapeutics
Bayer Fellow, 2009-2011 Manager, I&I Medical Information Celgene Corporation
Kyechin Chen, PharmD Bayer Fellow, 2012-2014 Channel Marketing Dexcom, Inc.
34
Bayer Fellowship Alumni Employed Elsewhere
Rutgers About Bayer Leadership Team Bayer Consumer Health
Tamy Recchia, PharmD
Bayer Fellow, 2006-2008 Associate Director, Medical Research; Medical Research & Strategy, Thrombosis Daiichi Sankyo
Sergio Gatoulis, PharmD
Vrunda Patel, PharmD
Anish Patel, PharmD
Chris Wang, PharmD
Adrienne Aiello, PharmD
John Vaile
John McBride
Bayer Fellow, 2006-2008 Project Director Parexel
Elias Gatoulis, PharmD, RPh
Shivani Gandhi
Elaine Nadeau, PharmD
Payal Patel, PharmD
Bayer Fellow, 2009-2011 Medical Science Liaison Acorda Therapeutics
Bayer Alum, 2010-2012 Director, Clinical Research Pfizer, Inc.
Bayer Pharmaceuticals Fellowship Alumni Employed at Bayer Employed Elsewhere Employed Elsewhere (cont'd)
Bayer Fellow, 2009-2011 Manager, Regulatory Intelligence Celgene
Bayer Fellow, 2008-2010 Manager, Global Medical Communications Genzyme
Bayer Fellow, 2014-2016 U.S. Regulatory Lead Amgen
Bayer Fellow, 2005-2007 Senior Director, Clinical Educators Pharmacyclics
Bayer Fellow, 2014-2016 Manager, Regulatory Affairs Advertising and Promotion Amgen
Bayer Fellow, 2005-2007 Associate Director Dermatology Unit Novartis
Bayer Fellow, 2012-2014 Associate Director in Regulatory Affairs Novartis
Bayer Fellow, 2010-2012 Medical Science Liaison, Neurology Acorda Therapeutics
35
36
